Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control

Published:2019-02 Issue: Volume:56 Page:67-75
ISSN:0952-7915
Container-title:Current Opinion in Immunology
language:en
Short-container-title:Current Opinion in Immunology

Author:

Andreakos Evangelos,Zanoni Ivan,Galani Ioanna E

Funder

Hellenic Ministry of Education, Research and Religious Affairs (MIDAS, RESOLVE-ASTHMA)

European Commission (PREDICTA, CURE, IMMUNAID, TAXINOMISIS)

Hellenic Foundation for Research and Innovation (RELIEVE)

National Institutes of Health

Harvard Digestive Diseases Center

CCFA Senior Research Award

Eleanor and Miles Shore 50th Anniversary Fellowship Program

Cariplo Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference70 articles.

1. Interferons at age 50: past, current and future impact on biomedicine;Borden;Nat Rev Drug Discov,2007

2. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex;Kotenko;Nat Immunol,2003

3. IL-28, IL-29 and their class II cytokine receptor IL-28R;Sheppard;Nat Immunol,2003

4. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus;Prokunina-Olsson;Nat Genet,2013

5. Lambda interferon inhibits hepatitis B and C virus replication;Robek;J Virol,2005

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of drug resistance against antiviral agents that target cellular factors;Virology;2024-12

2. Antiviral activity of adenoviral vector expressing human interferon lambda‐4 against influenza virus;Journal of Medical Virology;2024-04

3. Type III interferons in innate and adaptive immunity in the respiratory tract;Current Opinion in Immunology;2024-04

4. IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study;Cytokine;2024-04

5. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond;Seminars in Immunology;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3